Potassium channels: molecular defects, diseases, and therapeutic opportunities. - Wikidata - awgldk - TriplyDB

Potassium channels: molecular defects, diseases, and therapeutic opportunities.

Potassium channels: molecular defects, diseases, and therapeutic opportunities.

http://www.wikidata.org/entity/Q34106415

about

Arylbenzazepines are potent modulators for the delayed rectifier K+ channel: a potential mechanism for their neuroprotective effects Ion channel gene expression in the inner ear Neuronal and Cardiovascular Potassium Channels as Therapeutic Drug Targets: Promise and Pitfalls Novel roles for hERG K(+) channels in cell proliferation and apoptosis pH-Responsive, posttranslational regulation of the Trk1 potassium transporter by the type 1-related Ppz1 phosphatase.Peptidomimetic Star Polymers for Targeting Biological Ion Channels Kv2.1 ablation alters glucose-induced islet electrical activity, enhancing insulin secretion DV21 decreases excitability of cortical pyramidal neurons and acts in epilepsy.Shock Wave-Induced Damage of a Protein by Void Collapse The role of an inwardly rectifying K(+) channel (Kir4.1) in the inner ear and hearing loss.Potassium currents in isolated deiters' cells of Guinea pig.Molecular remodeling of ion channels, exchangers and pumps in atrial and ventricular myocytes in ischemic cardiomyopathy.Molecular diversity and functional evolution of scorpion potassium channel toxins The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia The application of the Escherichia coli giant spheroplast for drug screening with automated planar patch clamp system Electrophysiological remodeling in heart failure Unraveling monogenic channelopathies and their implications for complex polygenic disease Open conformation of hERG channel turrets revealed by a specific scorpion toxin BmKKx2 Probing the pH-dependent structural features of alpha-KTx12.1, a potassium channel blocker from the scorpion Tityus serrulatus An integrative model of ion regulation in yeast A practical approach to genetic hypokalemia.Multiscale model of dynamic neuromodulation integrating neuropeptide-induced signaling pathway activity with membrane electrophysiology.Plectasin, first animal toxin-like fungal defensin blocking potassium channels through recognizing channel pore region.Electrostatic interactions in the channel cavity as an important determinant of potassium channel selectivity.Effects of thymol on calcium and potassium currents in canine and human ventricular cardiomyocytes.hERG potassium channel blockage by scorpion toxin BmKKx2 enhances erythroid differentiation of human leukemia cells K562 Rehabilitating drug-induced long-QT promoters: in-silico design of hERG-neutral cisapride analogues with retained pharmacological activity.High yield purification of full-length functional hERG K+ channels produced in Saccharomyces cerevisiae.Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases.Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction Polycomb-dependent repression of the potassium channel-encoding gene KCNA5 promotes cancer cell survival under conditions of stress Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine.The Effects of the KCNQ Openers Retigabine and Flupirtine on Myotonia in Mammalian Skeletal Muscle Induced by a Chloride Channel Blocker.S100 calcium binding proteins and ion channels Antidystonic effects of Kv7 (KCNQ) channel openers in the dt sz mutant, an animal model of primary paroxysmal dystonia Membrane-delimited inhibition of maxi-K channel activity by the intermediate conductance Ca2+-activated K channel.Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety.Optimizing postoperative sexual function after radical prostatectomy Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects.Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.

P2860

Q21091199-590C6959-14ED-4EFF-AA7B-B7D5BEE6BDC9 Q24650344-3D43C7A2-4A56-40DA-9817-028956288E4A Q26798018-4356A00E-BB9A-4696-A3CE-BD2CA8234579 Q27015660-A8D35FF3-3511-4EFE-8050-ADF2E51DDB71 Q27937656-4AEE9A28-92B7-4331-894D-F9F692F037DD Q28550966-158D169B-3764-4256-B0D2-BDA8FEEA7FFE Q28588570-CC3BCBE6-5B1E-4877-BDAB-B7F5381FDF24 Q29994691-929A386C-E729-4817-8BB2-7FBF489AF6AF Q30366106-EF82CBCF-4447-4B92-93BE-413183B599D9 Q30414096-F8762F34-9EE9-46FE-9CE6-E6A5C5FF94FB Q30445278-759709DB-F24A-4C21-9C2D-84724EC02A05 Q33525464-92D5BE4B-4E9A-4901-AF99-492FA549EE4D Q33708620-FB0897CB-5E57-4ED2-A5DB-C8C8BE4F9BB5 Q33715775-6A4284D2-13E7-4258-AC5C-700A39AF15D9 Q33782923-9D755447-9BB5-4D11-88C1-C46FB0E8103D Q33887264-D090353B-67BD-4E22-B8E9-59A582C5C582 Q33905030-6B3CEB62-85A7-4F96-9D8D-3150DFD24497 Q33938901-8210D9D4-5222-4A90-9424-97519FE2CFEF Q34403695-7CC06BDB-8733-437A-AF98-30296DC1BF96 Q34558001-33A69C8D-90C5-4A62-9B55-F156D114EF59 Q34584743-731B6F22-CC22-4F8D-92B4-B89E285252A9 Q34863014-3C29486B-35A0-4575-AA8D-B2055E92DDCA Q35003632-EAC9B68B-8AAD-41C5-BA2C-219A85FF8613 Q35039384-2365792F-67F4-44F1-893D-8C9674FBCFA4 Q35044378-C1B635DC-92F9-48D2-9BB0-31FE288B1EBB Q35081094-83B44039-1501-43A4-AA65-34230C42079A Q35114020-5EF2125C-A840-4762-B85A-F36AF82B23DE Q35123689-0284E972-D350-4FB9-8E99-EAEAA3D9112B Q35500693-21A652A5-14BA-4DE9-A7E7-E37127028737 Q35545755-1BB0D4D9-F6BC-4AD6-81FA-A014E4949AD2 Q35672183-EF121DB8-38B3-49FF-B388-9A827D0F6031 Q35683922-2BE161BF-FAB7-4A6B-9B06-ADD763D120DB Q35872543-4C442285-7F23-4B0C-B1F3-8F3C2275B91E Q35911792-F31E9BA4-2365-4CDB-AAF9-1676F48D3C71 Q36054393-16926C31-D8C6-45EB-9AA9-3E212840A425 Q36295587-FFA66848-843C-493E-91C7-A68025DF0B7F Q36367355-6F833C31-306A-4E7F-9A7E-20B5552C450E Q36379338-2789BB41-B53D-460F-A7AB-6C940A94A218 Q36573243-2103B441-A76E-4DE3-B26D-428EA2251F0A Q36836444-3B5052FD-8D0A-4411-B0C4-DD9323902560

P2860

Potassium channels: molecular defects, diseases, and therapeutic opportunities.

http://www.wikidata.org/entity/Q34106415

description

2000 nî lūn-bûn

@nan

2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Potassium channels: molecular defects, diseases, and therapeutic opportunities.

@ast

Potassium channels: molecular defects, diseases, and therapeutic opportunities.

@en

Potassium channels: molecular defects, diseases, and therapeutic opportunities.

@nl

type

label

Potassium channels: molecular defects, diseases, and therapeutic opportunities.

@ast

Potassium channels: molecular defects, diseases, and therapeutic opportunities.

@en

Potassium channels: molecular defects, diseases, and therapeutic opportunities.

@nl

prefLabel

Potassium channels: molecular defects, diseases, and therapeutic opportunities.

@ast

Potassium channels: molecular defects, diseases, and therapeutic opportunities.

@en

Potassium channels: molecular defects, diseases, and therapeutic opportunities.

@nl

P1433

Q34106415-E20D224A-517A-493D-AC27-0C3BFED48A12

P1476

Q34106415-CEDD027C-3750-4678-B5B9-7521DF47DE05

P2093

Q34106415-14A88F78-6A3E-407C-B198-F09E1B1043E6

Q34106415-1D74BEDC-0653-41EA-972D-DCC993D38ED1

Q34106415-846BAF05-9CFF-4A81-8A57-4B9E3D6AE883

Q34106415-8CC4C0AA-1200-4615-8EFA-9518FF0CA118

P304

Q34106415-A37EE54C-9FAE-408D-92FC-87FAD669319E

P31

Q34106415-A8CC08DA-1DB0-4B5C-BE59-F1EE7C1B0315

P433

Q34106415-B4D269B0-1D8F-476C-9765-4CEB93645D10

P478

Q34106415-09A0390D-9F73-4468-8FFB-803033E272AD

P577

Q34106415-A90DEFBC-37A0-4291-9DD2-55413AB3E610

P698

Q34106415-475FF5FF-74DA-4F83-B8FE-1AA6B9900584

P1433

Pharmacological Reviews

P1476

Potassium channels: molecular defects, diseases, and therapeutic opportunities

@en

P2093

Coghlan M

http://www.w3.org/2001/XMLSchema#string

Gopalakrishnan M

http://www.w3.org/2001/XMLSchema#string

Shieh CC

http://www.w3.org/2001/XMLSchema#string

Sullivan JP

http://www.w3.org/2001/XMLSchema#string

P304

557-594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2000-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11121510

http://www.w3.org/2001/XMLSchema#string